Amgen Inc. (NASDAQ:AMGN) is one of the 11 stocks Jim Cramer put under the microscope recently. Cramer highlighted Wall Street ...

Mohammed Siraj spent a significant amount of time batting in the nets. He was playing defensive shots with lighter hands, and ...

In this Newshour Special Edition, Navika Kumar speaks to India’s top endocrinologist Dr Ambrish Mithal on the country’s ...

OZEMPIC-PENIS sounds like a sexually transmitted disease you really wouldn’t want to catch. But it’s actually a term that has cropped up online, largely amongst men on Reddit, who are saying ...

It can affect 1 in 100 patientsThe likes of Mounjaro, Ozempic and Wegovy are being associated with an inflamed ...

The GLP-1 drugs, including Mounjaro and Wegovy, work by mimicking the action of hormones that make you feel full, while ...

As the NHS rolls out Mounjaro being prescribed by GPs, weight loss jabs have been linked to potentially fatal side effects in new data ...

Join us as we play silly pranks on unsuspecting people in public, capturing their hilarious reactions with hidden cameras. Our channel is your go-to destination for non-stop laughter and comedy! 🔹 ...

More than 20 million people globally are injecting themselves with GLP-1s... Weight-loss pills will only see that explode ...

The way to shake the way you’re feeling about your friend’s choice,” counsels Eva Wiseman, “is to turn your gaze upon ...

Wegovy, a weight loss drug which reduces cardiovascular risks in obese individuals, launched in India on June 24. Experts break down its benefits and risks.

New GLP-1 weight-loss drugs are changing obesity treatment in India with promising health benefits. Dr. Ambrish Mithal, India's top endocrinologist, in an episode of Booked, highlights the impact of ...